Evaluating effectiveness of syringe exchange programmes: current issues and future prospects.
暂无分享,去创建一个
[1] C Latkin,et al. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[2] A. Diez-Roux,et al. Bringing context back into epidemiology: variables and fallacies in multilevel analysis. , 1998, American journal of public health.
[3] M E Halloran,et al. Study designs for dependent happenings. , 1991, Epidemiology.
[4] E. Franco,et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. , 1997, American journal of epidemiology.
[5] Julio S. G. Montaner,et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.
[6] R. Curtis,et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. , 1994, Social science & medicine.
[7] C. Hankins,et al. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal? , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[8] J. Parry,et al. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales , 1998, Epidemiology and Infection.
[9] F. Bastos,et al. Cities Responding to HIV-1 Epidemics among Injecting Drug Users , 1998 .
[10] M. Schechter,et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[11] M. Alary,et al. Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study". , 1998, American journal of epidemiology.
[12] T. Rhodes,et al. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. , 1999, AIDS.
[13] E. Franco,et al. DRS. BRUNEAU, LAMOTHE, AND FRANCO REPLY , 1998 .
[14] R Brookmeyer,et al. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. , 1995, American journal of epidemiology.
[15] D. Vlahov,et al. Syringe exchange not associated with social network formation: results from Baltimore , 2000, AIDS.
[16] M E Halloran,et al. Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.
[17] D. D. Des Jarlais,et al. Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. , 1998, Public health reports.
[18] R A Coutinho,et al. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. , 1994, American journal of public health.
[19] Martina Morris,et al. Epidemiology and Social Networks: , 1993 .
[20] Y. Cheung,et al. Harm Reduction: A New Direction for Drug Policies and Programs , 1998 .
[21] A. Ball. Overview: Policies and Interventions to Stem HIV-1 Epidemics associated with Injecting Drug Use , 1998 .
[22] E H Kaplan,et al. A method for evaluating needle exchange programmes. , 1994, Statistics in medicine.
[23] G A Satten,et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.
[24] J. Grund,et al. Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. , 1992, British journal of addiction.
[25] M. Martínez de Pancorbo,et al. The validation of statements by IDUs based on the analysis of blood traces on their used syringes. , 1998, AIDS care.
[26] R. Heimer,et al. Syringe use and reuse: effects of syringe exchange programs in four cities. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[27] M. Alter,et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. , 1995, American journal of public health.
[28] N. Weiss,et al. Syringe exchange and risk of infection with hepatitis B and C viruses. , 1999, American journal of epidemiology.
[29] S. Huttly,et al. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. , 1997, International journal of epidemiology.
[30] B Junge,et al. Satellite exchange in the Baltimore Needle Exchange Program. , 1998, Public health reports.
[31] M. Boily,et al. Mathematical Models of Disease Transmission: A Precious Tool for the Study of Sexually Transmitted Diseases , 1997, Canadian journal of public health = Revue canadienne de sante publique.
[32] D. D. Des Jarlais,et al. Maintaining low HIV seroprevalence in populations of injecting drug users. , 1995, JAMA.
[33] T. S. Jones,et al. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[34] E. V. van Ameijden,et al. Maximum impact of HIV prevention measures targeted at injecting drug users , 1998, AIDS.
[35] S. Friedman,et al. Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health? , 1999, Addiction.
[36] E H Kaplan,et al. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. , 1994, Journal of acquired immune deficiency syndromes.
[37] M. Halloran,et al. Causal Inference in Infectious Diseases , 1995, Epidemiology.
[38] R. Rothenberg,et al. Sociometric risk networks and risk for HIV infection. , 1997, American journal of public health.
[39] D. Vlahov,et al. Can HIV epidemics among injection drug users be prevented? , 1998, AIDS.
[40] M. Busch,et al. Use of a new 'less-sensitive enzyme immunoassay' testing strategy to identify recently infected persons in a Brazilian prison: estimation of incidence and epidemiological tracing. , 1999, AIDS.
[41] D. Vlahov,et al. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[42] J. Rich,et al. Detection of HIV‐1 nucleic acid and HIV‐1 antibodies in needles and syringes used for non‐intravenous injection , 1998, AIDS.
[43] Samuel R Friedman,et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes , 1996, The Lancet.
[44] R Brookmeyer,et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[45] K. Dolan,et al. AIDS behind bars: preventing HIV spread among incarcerated drug injectors. , 1995, AIDS.
[46] P. Lurie,et al. A Tale of Two Countries: Attempts to Control HIV among Injecting Drug Users in Australia and the United States , 1997 .
[47] M. Schechter,et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. , 1999, AIDS.
[48] L. Metsch,et al. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. , 2000, Drug and alcohol dependence.
[49] S. Aral. Heterosexual transmission of HIV: the role of other sexually transmitted infections and behavior in its epidemiology prevention and control. , 1993, Annual review of public health.
[50] J. Rich,et al. Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[51] A. Moss,et al. Invited commentary: needle exchange--no help for hepatitis? , 1999, American journal of epidemiology.
[52] G. Y. Wong,et al. Contextually Specific Effects and other Generalizations of the Hierarchical Linear Model for Comparative Analysis , 1991 .
[53] G. Stimson,et al. Drug injecting and HIV infection : global dimensions and local responses , 1998 .
[54] E H Kaplan,et al. Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users. , 1992, The Journal of infectious diseases.
[55] M. Morris,et al. Sexual networks and HIV. , 1997, AIDS.
[56] C. Archibald,et al. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. , 1998, AIDS care.
[57] T. S. Jones,et al. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[58] J. Kaldor,et al. Effectiveness of needle-exchange programmes for prevention of HIV infection , 1997, The Lancet.
[59] Sandra D. Lane,et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad , 1993 .
[60] E Massad,et al. HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[61] P Lurie,et al. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. , 1998, AIDS.
[62] Peter Lurie. Invited commentary: le mystère de Montréal. , 1997, American journal of epidemiology.
[63] S. Strathdee,et al. Drug Use and the Spread of HIV/AIDS in South America and the Caribbean , 1999 .
[64] G. Stimson,et al. Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales. , 1993, Addiction.
[65] G. Stimson. AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. , 1995, Social science & medicine.
[66] K. Vranizan,et al. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[67] Patricia G. Erickson,et al. 18 Two Steps Forward, One Step Back: Anti-User Bias in New York State's Approach to Needle Exchange , 1997 .
[68] P. Lurie,et al. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA , 1997, The Lancet.
[69] R. Brookmeyer,et al. Measuring HIV-1 incidence in northern Thailand: prospective cohort results and estimates based on early diagnostic tests. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[70] R. Heimer,et al. Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens. , 1996, The Journal of infectious diseases.
[71] R. Booth,et al. The prevalence of additional injection-related HIV risk behaviors among injection drug users. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[72] M. Kretzschmar,et al. Modelling the spread of HIV in social networks of injecting drug users , 1998, AIDS.
[73] J. Wrench,et al. Outbreak of HIV infection in a Scottish prison , 1995, BMJ.
[74] D. Hartel,et al. Needle exchange use among a cohort of injecting drug users , 1996, AIDS.
[75] D. Jolley,et al. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm‐reduction programme , 1995, AIDS.
[76] Arthur L. Reingold,et al. Public Health Impact of Needle Exchange Programs in the United States and Abroad: Summary, Conclusions, and Recommendations, The , 1993 .
[77] P. Telles. Preventing HIV/AIDS and other sexually transmitted diseases among injecting drug users in Rio de Janeiro , 1999 .
[78] E. Franco,et al. Assessing Harm Reduction Strategies: The Dilemma of Observational Studies , 1997 .
[79] Thomas W. Valente. Network models of the diffusion of innovations , 1996, Comput. Math. Organ. Theory.
[80] R. Brookmeyer,et al. The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. , 1995, American journal of epidemiology.
[81] P. Lurie. DR. LURIE REPLIES , 1998 .
[82] M Susser,et al. The logic in ecological: I. The logic of analysis. , 1994, American journal of public health.
[83] D. Purchase,et al. Syringe exchange in the United States, 1996: a national profile. , 1999, American journal of public health.
[84] J. Nelles,et al. Preventing HIV transmission in prison: a tale of medical disobedience and Swiss pragmatism , 1995, The Lancet.
[85] R. Anderson,et al. Human Immunodeficiency Virus Transmission and the Role of Other Sexually Transmitted Diseases: Measures of Association and Study Design , 1996, Sexually transmitted diseases.
[86] R A Coutinho,et al. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. , 1989, American journal of public health.